Previous close | 170.06 |
Open | 170.06 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 800 |
Day's range | 170.06 - 173.79 |
52-week range | 100.57 - 176.93 |
Volume | |
Avg. volume | 1,713,806 |
Market cap | 45.25B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.68 (2.15%) |
Ex-dividend date | 01 Mar 2024 |
1y target est | N/A |
Insightful Analysis of Allstate Corp's Financial Health and Strategic Position
The headline numbers for Allstate (ALL) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Insurer Allstate posted an upbeat first-quarter profit on Wednesday, helped by higher premiums and stronger investment returns. Allstate's adjusted first-quarter swung to a profit of $5.13 per share in the three months ended March 31 from a loss of $1.30 per share in the year ago quarter. The company's consolidated premiums written for the quarter were at $14.29 billion, up 11.1% from the year-ago quarter.